Skip to content
Insider tapeFilings through Fri, Oct 2
Watchlist

Shannon Thyme Klinger

General Counsel at Moderna, Inc. (MRNA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 3SEC MRNAModerna, Inc. Sell Plan 3,471 $139.95 $486K +45.2%
Jun 8SEC MRNAModerna, Inc. Sell Plan 3,471 $50.00 $174K +306.4%
Mar 3SEC MRNAModerna, Inc. Sell Plan 13,885 $52.29 $726K +288.6%
  • Sell

    General Counsel Shannon Thyme Klinger sold $486K of MRNA at $139.95 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Shannon Thyme Klinger sold $174K of MRNA at $50.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Shannon Thyme Klinger sold $726K of MRNA at $52.29 — pre-scheduled 10b5-1 plan sale.